Marcela Maus: Closing plenary to explore the future of CAR T-Cell therapy in solid tumors
Mediamedic posted on LinkedIn:
”Closing Plenary: The Future of CAR T-Cell Therapy in Solid Tumors
The final plenary of Tandem Meetings 2025, chaired by Dr. Marcela Maus (Massachusetts General Hospital Cancer Center, Harvard Medical School), explored the next frontier in cellular immunotherapy – expanding CAR T-cell therapy from hematologic cancers to solid tumors.
Speakers Dr. Saul Priceman (USC) and Dr. Julia Carnevale (UCSF) presented cutting-edge research on tumor microenvironment modulation, CRISPR-based functional genomics, and next-generation T-cell engineering aimed at overcoming T-cell exhaustion and antigen heterogeneity.
“This closing plenary offers an exciting glimpse into the future of cellular therapeutics,” said Dr. Maus. “We are united in improving the patient experience and curing disease by leveraging cells as medicine.” ”
Find more here.

Stay updated with Hemostasis Today.
-
Jul 11, 2026, 21:44Timos Papagatsias: From Promising Concepts to Clinical Differentiation at ISTH 2026
-
Jul 11, 2026, 21:43Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US
-
Jul 11, 2026, 21:41Bianca Constantin: Don’t Miss the ISTH Early Career Committee Activities
-
Jul 11, 2026, 21:38Fateme Babaha: Don’t Miss Your Favorite ISTH 2026 Sessions
-
Jul 11, 2026, 21:11Farjah Algahtani: Learning, Sharing, and Collaborating at ISTH 2026
-
Jul 11, 2026, 19:56Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
-
Jul 11, 2026, 19:38Lynn Kloeckner: Recognizing Kirsten Lacine’s Impact on the Stroke Survivor Journey
-
Jul 11, 2026, 19:19Rens De Groot: New Proteomic Evidence Reveals Early Hemolysis During ADAMTS13 Relapse in Immune TTP
-
Jul 11, 2026, 19:01Laurent Bertoletti: Honoring the Legacy of Guy Meyer and the INNOVTE Network at ISTH 2026